Related Experiment Videos
Lemierre's syndrome and genetic polymorphisms: a case report
Jean-Michel Constantin1, Jean-Paul Mira, Renaud Guerin
1Adult Intensive Care Unit, Department of anesthesiology and intensive care, University Hospital of Clermont-Ferrand, Hotel-Dieu Hospital, F-63058 Clermont-Ferrand, France. jmconstantin@chu-clermontferrand.fr
BMC Infectious Diseases
|July 19, 2006
Summary
Genetic variations in immune response and blood clotting may explain Lemierre's syndrome, a rare but serious condition. Further genomic studies are needed to fully understand its pathophysiology.
Area of Science:
- Genetics
- Immunology
- Pathophysiology
Background:
- Lemierre's syndrome is a clinical condition with an unclear pathophysiology.
- Research has explored genetic predispositions influencing host pathogen detection and systemic reactions.
Observation:
- A case study of a 17-year-old female with Lemierre's syndrome, septic shock, and acute respiratory distress syndrome was analyzed.
- Genetic analysis revealed functional variations in the Toll-like receptor 5 (TLR 5) gene.
- The patient also exhibited two coagulation variations: Tissue Factor (TF) 603 and Plasminogen-Activator-Inhibitor-1 (PAI-1) 4G-4G homozygosity.
Findings:
- The observed genetic variations, specifically in TLR 5 and prothrombotic factors (TF, PAI-1), were associated with thrombotic events.
- These genetic factors may contribute to the development and severity of Lemierre's syndrome.
Implications:
- The findings suggest that the innate immune response and prothrombogenic mutations play a role in Lemierre's syndrome.
- Genomic studies in multiple patients are recommended to elucidate the complete pathophysiology of Lemierre's syndrome.